New data suggest InterMune Inc.'s intravenous oritavancin is as effective as a regimen of vancomycin plus cephalexin in treating patients with complicated skin and skin-structure infections (CSSSI).
Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Combining Microneedling and Tranexamic Acid for Melasma: Efficacy and Satisfaction
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp